345 related articles for article (PubMed ID: 1732739)
1. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
Ryseck RP; Bull P; Takamiya M; Bours V; Siebenlist U; Dobrzanski P; Bravo R
Mol Cell Biol; 1992 Feb; 12(2):674-84. PubMed ID: 1732739
[TBL] [Abstract][Full Text] [Related]
2. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
Kamens J; Brent R
New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
La Rosa FA; Pierce JW; Sonenshein GE
Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
[TBL] [Abstract][Full Text] [Related]
4. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
[TBL] [Abstract][Full Text] [Related]
5. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
Bours V; Burd PR; Brown K; Villalobos J; Park S; Ryseck RP; Bravo R; Kelly K; Siebenlist U
Mol Cell Biol; 1992 Feb; 12(2):685-95. PubMed ID: 1531086
[TBL] [Abstract][Full Text] [Related]
6. Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif.
Dobrzanski P; Ryseck RP; Bravo R
Mol Cell Biol; 1993 Mar; 13(3):1572-82. PubMed ID: 8441398
[TBL] [Abstract][Full Text] [Related]
7. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.
Ruben SM; Narayanan R; Klement JF; Chen CH; Rosen CA
Mol Cell Biol; 1992 Feb; 12(2):444-54. PubMed ID: 1732726
[TBL] [Abstract][Full Text] [Related]
9. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Jiang HY; Petrovas C; Sonenshein GE
J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
[TBL] [Abstract][Full Text] [Related]
10. Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae.
Moore PA; Ruben SM; Rosen CA
Mol Cell Biol; 1993 Mar; 13(3):1666-74. PubMed ID: 8441404
[TBL] [Abstract][Full Text] [Related]
11. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
Diehl JA; Hannink M
J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
[TBL] [Abstract][Full Text] [Related]
12. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
Schatzle JD; Kralova J; Bose HR
J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant.
Logeat F; Israël N; Ten R; Blank V; Le Bail O; Kourilsky P; Israël A
EMBO J; 1991 Jul; 10(7):1827-32. PubMed ID: 1675604
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
Tewari M; Dobrzanski P; Mohn KL; Cressman DE; Hsu JC; Bravo R; Taub R
Mol Cell Biol; 1992 Jun; 12(6):2898-908. PubMed ID: 1588976
[TBL] [Abstract][Full Text] [Related]
15. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
Diehl JA; McKinsey TA; Hannink M
Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
[TBL] [Abstract][Full Text] [Related]
16. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
[TBL] [Abstract][Full Text] [Related]
17. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
Weih F; Carrasco D; Bravo R
Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
[TBL] [Abstract][Full Text] [Related]
18. GAL4-I kappa B alpha and GAL4-I kappa B gamma activate transcription by different mechanisms.
Morin PJ; Subramanian GS; Gilmore TD
Nucleic Acids Res; 1993 May; 21(9):2157-63. PubMed ID: 8502557
[TBL] [Abstract][Full Text] [Related]
19. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
